Reducing the Risk of Thromboembolism in Cancer

 

Although parenteral thromboprophylaxis can reduce the risk of venous thromboembolism in patients undergoing chemotherapy, the absolute risk reduction is modest, there is a risk of major bleeding, the cost is high, and daily injections are required.